Concepedia

Masanori Atsukawa

MA

Statistics

Publications

140

Citations

5.1K

H-Index

39

Active since

2009

Affiliations

Nippon Medical School(Current)

Ogaki Municipal Hospital

Kagawa Prefectural Central Hospital

Ehime Prefectural Central Hospital

Saiseikai Niigata Daini Hospital

Masanori Atsukawa is an author at Nippon Medical School specializing in medicine, oncology, and pharmacotherapy.

ORCID

Publications per year

2009–2024

140

Publications

140

Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial

Yoshiyuki Narahara, Hidenori Kanazawa, Takeshi Fukuda et al. · Journal of Gastroenterology · 2010 · 168 citations

, , +11

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis

Atsushi Hiraoka, Takashi Kumada, Masanori Atsukawa et al. · Cancer Medicine · 2019 · 159 citations · Full text

, , +13

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis

Atsushi Hiraoka, Takashi Kumada, Kazuya Kariyama et al. · Cancer Medicine · 2018 · 132 citations · Full text

, , +15

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima et al. · ESMO Open · 2022 · 130 citations · Full text

, , +14

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

Andrea Casadei‐Gardini, Margherita Rimini, Toshifumi Tada et al. · European Journal of Cancer · 2022 · 129 citations · Full text

, , +15

1–5 of 140